Viral infections biotech ENA Respiratory inhales $3 million from government fund
AI Summary
ENA grabs $3m to push its virus-fighting nasal spray into asthma trials to outsmart flu, RSV and COVID.
Discussion
Sign in to join the discussion.
Loading comments…